TY - JOUR T1 - A fasting plasma glucose level ≥7.8 mmol/l was sensitive but not specific for identifying poor glycaemic control JF - Evidence Based Medicine JO - Evid Based Med SP - 94 LP - 94 DO - 10.1136/ebm.5.3.94 VL - 5 IS - 3 A2 - , Y1 - 2000/05/01 UR - http://ebm.bmj.com/content/5/3/94.abstract N2 - (1999) Diabetes Care 22, 904; Bouma M, Dekker JH, de Sonnaville JJ, et al.. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?. Jun;. :. –7.OpenUrlAbstract
 
 QUESTION: In patients with type 2 diabetes mellitus who are not using insulin, how do fasting plasma glucose (FPG) measurements compare with those of glycosylated haemoglobin (HbA1c) in determining glycaemic control? Comparison of 2 laboratory tests. A family practice in Amsterdam, the Netherlands. 1020 patients who were >40 years of age (mean age 64 y, 67% women), had type 2 diabetes (median duration 2.4 y), were not pregnant, and were not taking insulin. FPG levels were measured in venous plasma by the glucose oxidase method (Boehringer-Mannheim, Mannheim, Germany) and by the glucose dehydrogenase method (Merck, Darmstadt, Germany). HbA1c was measured using high performance liquid chromatography. The sensitivity and specificity of an FPG level of 7.8 mmol/l was calculated with reference to the HbA1c diagnostic standard cut points of 6.5% and 7.0%. These cut points … ER -